Topics

Propylene Oxide Sds Section 3 Breakdown Reading Carcinogen Exposure Declarations

Propylene Oxide SDS Section 3 Breakdown: Reading Carcinogen & Exposure Declarations

Propylene oxide (PO), CAS 75-56-9, EC 200-879-2, is a low-boiling epoxide monomer used principally in polyether polyol trains, propylene glycol ether synthesis, and certain industrial coating intermediates. The safety data sheet entry under Section 3 is a composition disclosure field, not a process control specification or a quantitative exposure assessment. A reader who treats Section 3 as a substitute for Section 8 exposure limits or Section 9 physical property data will systematically miss the fields that drive ventilation design, personal protective equipment selection, and medical surveillance.

Section 3 of a GHS-aligned SDS is titled “Composition/information on ingredients.” Under 29 CFR 1910.1200 Appendix D in the United States and under REACH Annex II in the European Union, the section must identify substances that contribute to the hazard classification of the material. For propylene oxide as a neat product, the line entry generally includes the chemical name, CAS registry number, EC number, Index number where applicable, and an exact percentage or a narrow concentration range. For a formulated mixture containing PO, the same identifiers appear with a mass-percent interval such as 0.1–1%, 1–5%, or 5–10%, depending on the formulation. The interval is not decorative; it controls downstream mixture classification under GHS and determines whether the PO hazard classes propagate into the Section 2 label signal.

Within a Section 3 line item for propylene oxide, the sequence of identifiers resolves synonyms that can otherwise obstruct hazard communication. Common synonyms appearing on supplier SDSs include 1,2-epoxypropane, methyloxirane, and propene oxide. The CAS and EC numbers are the stable keys for linking the line item to authoritative regulatory inventories. A process safety professional reading a PO SDS should verify that the CAS entry is 75-56-9 and not 75-21-8, the latter being ethylene oxide. The two substances are both epoxide monomers, but their exposure limits, carcinogen classifications, and physical hazard profiles differ materially.

What a GHS-Aligned Section 3 Entry Must Disclose for Propylene Oxide

The harmonised classification for propylene oxide under Regulation (EC) No 1272/2008 Annex VI includes Flam. Liq. 1, Carc. 1B, Muta. 1B, Acute Tox. 4, Skin Irrit. 2, Eye Irrit. 2, and STOT SE 3. The corresponding GHS hazard statement codes are H224, H350, H340, H332, H315, H319, and H335. In a Section 3 table for propylene oxide, these codes accompany the ingredient concentration, not the protective measures. The reader should translate each code independently: H224 identifies the extreme flammability hazard from the liquid and vapour, while H350 identifies carcinogenic potential and H340 identifies germ cell mutagenicity. The simultaneous presence of H350 and H340 is what triggers the mixture listing threshold of 0.1% w/w for carcinogenic and mutagenic constituents in non-gaseous mixtures under the CLP framework.

For a pure propylene oxide stream, Section 3 may state a principal component concentration of ≥99% or ≥99.9%, with residual water and carbonyl impurities reported batch-specifically. The exact value is supplier-specific. If a trade secret claim is maintained for an exact concentration, the range must still be disclosed when propylene oxide is present at or above the relevant threshold. A Section 3 range such as 10–30% in a formulated product is read differently from 0–0.1% because the latter may fall below the carcinogen disclosure trigger for that specific formulation. The Section 3 concentration field also feeds into Section 14 transport classifications and Section 9 physical property estimates for the mixture, though it does not replace mixture-specific test data.

When Section 3 is prepared for a polymer-grade PO transfer, the reader should cross-check the listed concentration against the certificate of analysis and the process stream specification. In bulk monomer storage and feed systems, the SDS line entry often contains only the main component and does not itemise trace stabilisers unless those stabilisers are independently classified as hazardous. A stabiliser package that is present below the applicable cut-off may be omitted. The omission is not a signal that the stabiliser is irrelevant; it is a threshold-based disclosure outcome. For PO stored in long-loop systems, stabiliser depletion can influence downstream reactivity, but that operational concern is not declared inside Section 3.

When Section 3 Lists H350 and H340, the Exposure Declaration is Hazard-Based, Not Quantitative

The H350 statement “may cause cancer” in a propylene oxide SDS is a hazard declaration. It does not carry a numerical airborne concentration limit, a time-weighted average, or a short-term exposure ceiling. The same applies to H340, which declares mutagenic potential but does not specify an exposure route or a dosimetric threshold. A Section 3 entry for PO therefore answers the question “does this material belong to a recognised carcinogen hazard class?” and does not answer the question “at what air concentration is exposure acceptable?” The latter is addressed in Section 8, where the occupational exposure limit table is located.

The regulatory carcinogen statements for propylene oxide sit in several inventories. IARC Monographs Volume 60 assigns Group 2B, “possibly carcinogenic to humans.” The NTP Report on Carcinogens lists propylene oxide as reasonably anticipated to be a human carcinogen. The California Office of Environmental Health Hazard Assessment includes propylene oxide on the Proposition 65 list as a chemical known to the State of California to cause cancer. None of these inventory entries is a GHS hazard code, and none belongs in a Section 3 line item unless the supplier voluntarily adds a supplementary note. The GHS language is the legal classification; the IARC, NTP, and Proposition 65 entries are hazard identification statements from separate regulatory frameworks.

Some suppliers annotate the Section 3 entry with route-specific language such as “may cause cancer by inhalation” or “exposure by inhalation and ingestion should be prevented.” This wording is supplementary. The harmonised Annex VI entry for propylene oxide uses the general H350 code without a route restriction. If a supplier applies H350i, the route-specific inhalation cancer statement, it should be documented with a self-classification rationale. A hygienist reviewing the SDS should not assume that a general H350 entry implies a defined unit risk factor, nor should the absence of route-specific wording be interpreted as evidence of low inhalation concern. The classification is hazard-based, not concentration-based.

CodeHazard ClassHazard StatementRelevance for Exposure Reading
H224Flam. Liq. 1Extremely flammable liquid and vaporDrives vapour release and area classification during sampling
H350Carc. 1BMay cause cancerTriggers 0.1% w/w listing threshold and carcinogen control programme
H340Muta. 1BMay cause genetic defectsTriggers 0.1% w/w listing threshold and medical surveillance review
H332Acute Tox. 4Harmful if inhaledSupports inhalation exposure assessment and respirator programme review
H315Skin Irrit. 2Causes skin irritationIndicates need for dermal contact control and glove selection
H319Eye Irrit. 2Causes serious eye irritationIndicates need for eye protection during transfer and sampling
H335STOT SE 3May cause respiratory irritationRelevant for short-term exposure interpretation and confined-space entry

The table above is a classification map, not an exposure limit matrix. It should be read in parallel with Section 8, which for propylene oxide may list multiple occupational exposure limits depending on the jurisdiction. The Section 3 table tells the reader that the material is a carcinogen, a mutagen, a respiratory tract irritant, and a highly flammable liquid. It does not state how many parts per million constitute overexposure under a specific occupational exposure limit.

Occupational Exposure Limits and Medical Surveillance Triggers

Quantitative exposure declarations for propylene oxide are located outside Section 3. In the United States, the OSHA permissible exposure limit is 100 ppm (240 mg/m³) as an 8-hour time-weighted average under 29 CFR 1910.1000 Table Z-1. The NIOSH Recommended Exposure Limit is 20 ppm (48 mg/m³) as a TWA with a skin notation and a carcinogen designation. The ACGIH threshold limit value is 2 ppm (4.8 mg/m³) as an 8-hour TWA with an A3 notation, meaning confirmed animal carcinogen with unknown relevance to humans. These values are not harmonised, and the Section 3 hazard code alone should not be used to choose among them. The hygienist must consult the local regulatory exposure limit applicable to the site and then select the more protective control band where the classification and the exposure limit diverge.

SourceLimit TypeValueNotation
OSHA 29 CFR 1910.1000 Table Z-18-hour TWA PEL100 ppm (240 mg/m³)No skin notation
NIOSH Pocket GuideRecommended exposure limit20 ppm (48 mg/m³) TWACa; skin; IDLH 400 ppm
ACGIH TLV8-hour TWA2 ppm (4.8 mg/m³)A3 confirmed animal carcinogen

The skin notation in the NIOSH recommendation is significant for propylene oxide because the compound is volatile and can also be absorbed through intact skin at operationally relevant rates. A Section 3 hazard table will not carry the skin notation. Similarly, the Ca designation in the NIOSH limit means that the agency recommends treating PO as a potential occupational carcinogen, which is a statement about administrative control, not a chemical identity field. When a safety review assigns a respirator or glove specification, the source data must come from Section 8 and the relevant exposure standard, not from the Section 3 composition table.

Biological monitoring for propylene oxide exposure may utilise haemoglobin adduct measurement, such as N-(2-hydroxypropyl)valine adducts in blood. This endpoint is not declared in the SDS Section 3 composition entry. It belongs to an occupational medicine programme and is used to estimate integrated exposure over the erythrocyte lifespan when air monitoring alone is insufficient to resolve peak episodic exposures during pump work, sampling, or line-break operations. The presence of H340 in the Section 3 entry is often the administrative trigger for considering this biomonitoring endpoint, but the biomarker method and the analytical sensitivity are not SDS content.

Mixed Hazard Declarations in Low-Volume Research and Polymer-Grade Transfers

In a research laboratory handling PO as a reagent or intermediate, Section 3 may appear in a kit component SDS or a supplier-generated extended safety data sheet. The concentration field often reads 100% for a pure reagent, but the hazard declaration remains the same as for bulk monomer. The difference is operational: small-volume use in a fume hood does not eliminate the carcinogen and mutagen designation, nor does it remove the need for a documented exposure evaluation. The Section 3 line entry is a constant; the work environment and engineering controls are the variables.

Production-scale PO transfer systems typically use magnetic-drive sealless pumps or mechanically sealed pumps with nitrogen-purged barrier fluid to reduce fugitive emissions at the rotating shaft. The SDS Section 3 composition table does not specify this equipment. However, the combination of H224, H350, and H340 in the line entry is the trigger for selecting the equipment class, the area classification, the leak detection strategy, and the maintenance access protocol. A pump seal leak in a PO service loop is therefore evaluated against both the flammable vapour cloud potential and the carcinogen exposure implications. The SDS Section 3 entry supplies the hazard classification; the equipment standard supplies the leak containment boundary.

For PO-containing formulated products, such as a polyol blend or a laboratory resin component, the Section 3 table may show propylene oxide at a range that crosses a classification threshold. The reader should verify whether the range is given as a percentage by weight or volume, because units affect the regulatory cut-off comparison. If the concentration is stated as 0.5–1.5% by weight, the formulation may or may not be classified as carcinogenic depending on the exact batch and the mixture-level evaluation. If the range is stated as 0.05–0.15%, the batch can straddle the 0.1% w/w Carc. 1B disclosure trigger. In such a case, the Section 3 data must be read with the Section 2 classification and the Section 15 regulatory statements to confirm which hazards propagate into the final mixture classification.

The vapour pressure of propylene oxide is approximately 59 kPa at 20°C, and the flash point is -37°C. These physical data points are not Section 3 fields, but they explain why a composition entry indicating 100% PO generates an immediate vapour exposure and explosion hazard at ambient temperature. A closed-transfer system with vapour recovery is normally required for bulk operations. Section 3 declares what the material is and what hazard classes it belongs to; Section 9 declares how fast it becomes airborne. Both are necessary for a functional exposure narrative, but they are not interchangeable.

The presence of H350 and H340 in the PO Section 3 entry also interacts with waste classification, release reporting, and residue disposal decisions. Propylene oxide is listed as a hazardous air pollutant under Clean Air Act Section 112(b), and the Section 3 hazard codes can trigger regulatory applicability review in downstream operations. However, the specific emission threshold, reporting quantity, or waste code must be verified in the relevant environmental regulation, not inferred from the SDS composition table. A common misreading is to treat the H224 flammable hazard as the dominant risk because it is listed first in some supplier tables. The ordering of codes in Section 3 is not a priority ranking.

When the Section 3 entry for propylene oxide is compared across suppliers, the concentration ranges, trade secret intervals, and supplementary toxicology notes may differ even though the underlying CAS number and the harmonised GHS classification remain stable. The reader should normalise supplier differences to the CAS number and the hazard code set, not to the trade name or the section formatting. Published data for this specific configuration is limited where proprietary stabiliser packages are claimed as trade secrets, but the core carcinogen and mutagen declarations remain harmonised through the cited regulatory inventories.

Top